BioCardia, Inc. (BCDA)
NASDAQ: BCDA · Real-Time Price · USD
0.9476
+0.0802 (9.25%)
At close: Jun 17, 2026, 4:00 PM EDT
0.9447
-0.0029 (-0.31%)
Pre-market: Jun 18, 2026, 8:26 AM EDT
BioCardia Employees
As of December 31, 2025, BioCardia had 21 total employees, including 17 full-time and 4 part-time employees. The number of employees increased by 1 or 5.00% compared to the previous year.
Employees
21
Change (1Y)
1
Growth (1Y)
5.00%
Revenue / Employee
n/a
Profits / Employee
-$370,238
Market Cap
10.78M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 21 | 1 | 5.00% | 17 | 4 |
| Dec 31, 2024 | 20 | 0 | - | 17 | 3 |
| Dec 31, 2023 | 20 | -16 | -44.44% | 16 | 4 |
| Dec 31, 2022 | 36 | 1 | 2.86% | 30 | 6 |
| Dec 31, 2021 | 35 | 6 | 20.69% | 28 | 7 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Jun 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
Related Stocks
| Company Name | Employees |
|---|---|
| SeaStar Medical Holding | 17 |
| Theriva Biologics | 16 |
| BioRestorative Therapies | 14 |
| Kiora Pharmaceuticals | 13 |
| Aprea Therapeutics | 8 |
| Intensity Therapeutics | 7 |
| Traws Pharma | 7 |
| Jupiter Neurosciences | 5 |
BCDA News
- 10 days ago - BioCardia Announces $4.4 Million Financing - GlobeNewsWire
- 13 days ago - FDA confirms CardiAMP Heart Failure II Trial may support premarket approval - TheFly
- 13 days ago - FDA Confirms CardiAMP HF II May Support Premarket Approval of CardiAMP Cell Therapy for Ischemic HFrEF - GlobeNewsWire
- 4 weeks ago - BioCardia Announces CardiAMP Chronic Myocardial Ischemia Trial Results Presented at EuroPCR Showed Durable Improvements in Exercise Tolerance with Reduced Angina Frequency - GlobeNewsWire
- 4 weeks ago - BioCardia Transcript: A.G.P.'s Annual Virtual Healthcare Conference - Transcripts
- 4 weeks ago - BioCardia Earnings Call Transcript: Q1 2026 - Transcripts
- 4 weeks ago - BioCardia Earnings release: Q1 2026 - Filings
- 4 weeks ago - BioCardia Quarterly report: Q1 2026 - Filings